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Background: Comet assay is a quick method for assessing DNA damage in individual cells. It allows the detection
of single and double DNA strand breaks, which represent the direct effect of some damaging agents. This study
uses standard comet quantification models to compare the neurotoxic effect of orally administered propionic acid
(PA) to that produced as a metabolite of bacterial overgrowth induced by clindamycin. Additionally, the protective
effect of carnosine and carnitine as natural dietary supplements is assessed.
Methods: Single cell gel electrophoresis (comet assays) were performed on brain cortex and medulla samples after
removal from nine groups of hamsters including: a control (untreated) group; PA-intoxicated group; clindamycin
treated group; clindamycin-carnosine group and; clindamycin-carnitine group.
Results: There were significant double strand breaks recorded as tail length, tail moment and % DNA damage in
PA and clindamycin-treated groups for the cortex and medulla compared to the control group. Neuroprotective
effects of carnosine and carnitine were observed. Receiver Operating Characteristics curve (ROC) analysis showed
satisfactory values of sensitivity and specificity of the comet assay parameters.
Conclusion: Percentage DNA damage, tail length, and tail moment are adequate biomarkers of PA neurotoxicity
due to oral administration or as a metabolite of induced enteric bacterial overgrowth. Establishing biomarkers of
these two exposures is important for protecting children’s health by documenting the role of the imbalance in gut
microbiota in the etiology of autism through the gut-brain axis. These outcomes will help efforts directed at
controlling the prevalence of autism, a disorder recently related to PA neurotoxicity.
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reproduction in any medium, provided the orespecially in children. Animal studies may help identify
the etiology of neurotoxicity due to some of these envi-
ronmental chemicals. Additionally, animal studies can
help understanding the protective effects of some dietary
supplements against neurotoxicity. Due to the high
number of reports of antibiotic exposure, hospitalization,
and gastrointestinal disturbances [1-3] in many children
with autism spectrum disorders (ASDs), the neurobio-
logical effects of microbiota-produced short-chain fatty
acids (SCFAs), such as propionic acid (PA) has been
examined [4-7].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nificantly greater diversity of bacteria in the feces of autistic
subjects compared to control subjects. The increased
microflora in autistic children may contain harmful genera
or species contributing to the severity of autistic symptoms
[8]. Two examples are Bacteroidetes and Firmicutes. The
vast majority of species in the Bacteroidetes phylum pro-
duce propionic acid and lipopolysaccharides (LPS), which
are well-known virulence factors.
The presence and abundance of Clostridium in the
intestines of autistic children is well documented. Finegold
[9] hypothesized that the relapse of some autistic children
after antibiotic treatment is due to Clostridium spores.
The incidence of autism is related to widespread exposure
to Clostridium spores, and the increase of multiple cases
of autism within a single family is also related to contact
with spores [9]. Propionate has been shown to have severe
neurological effects in rats [10,11] and Clostridia produce
propionate [12]. Studies by MacFabe et al. (2007) [10]
have demonstrated that injecting propionate directly into
specific regions of rat brains in vivo can cause significant
behavioral problems.
MacFabe et al. (2007) [10] postulated that the overuse
of antibiotics that has contributed to an increase in patho-
genic bacteria of which Clostridium infections could be
playing a role in the pathophysiology of autism. Addition-
ally, clindamycin-treated hamsters are predictably susceptible
to infection with pathogenic strains of Clostridium difficile
and, as an animal model, they parallel most of the important
aspects of human C. difficile associated disease (CDAD) [13].
A number of important observations were reported when a
small amount of PA was infused into the brains of rodents
[10]. Impact on socialization and behavior was also evaluated
in a novel gut-mediated autism model [11]. Infusion with
small amounts of PA resulted in social impairment, repetitive
behavior and obsessive-compulsive behavior [14].
Concern has been expressed over the alarming increase
in the rates of ASDs worldwide. Evaluation of the outcomes
of oral administration of PA may aid in the understanding
of these disorders. Hence, the present study was under-
taken to investigate and evaluate the genotoxic effects asso-
ciated with the oral administration of PA in comparison to
overgrowth of intestinal microbiota induced in hamsters
that received clindamycin. The study was extended to in-
vestigate the neuroprotective effects of carnosine and carni-
tine. Evaluation was done at the genotoxic levels through
the use of tail length and tail moment to evaluate DNA
damage as a marker of neurotoxicity.
Material and methods
Chemicals
Propionic acid, carnosine and carnitine were of analytical
grade from Sigma-Aldrich. Clindamycin was purchased
from Pharmacia Co., Peapack, NJ, USA.Animals
A total of 54 young male golden Syrian hamsters weighing
approximately 80–100 g (8 weeks of age) were used in the
present study. Animals were randomly allocated to one of
9 groups consisting of 6 animals each: a control group that
received only phosphate buffered saline; an oral buffered
PA-treated group that was given a neurotoxic dose of
250 mg/kg body weight/day for 3 days [15]; a clindamycin-
treated group that received a single dose (orogastrically) of
30 mg/kg on experiment day 0; a carnosine-treated group
that received a dose of 10 mg/kg body weight/day orally
(daily for one week); a carnitine-treated group that received
50 mg/kg body weight/day orally (daily for one week) and;
four protected groups were given the same doses of
carnosine or carnitine for one week followed by PA for 3 -
days or a single dose of clindamycin as described above.
All groups were kept at a controlled temperature (21 ±
1°C) with ad-libitum access to food and water. Quantita-
tive stool cultures were collected and tested both aerobic-
ally and anaerobically on groups of hamsters receiving
clindamycin and the untreated controls. All experiments
were performed in accordance with national animal care
guidelines and were pre-approved by the faculty ethics
committee, King Saud University.
Brain tissue preparation
At the end of the experiment, hamsters were anesthe-
tized with carbon dioxide. The brain was removed from
the skull and the cortex and medulla were extracted.
Brain tissues of the nine groups were kept at −80°C until
use.
Single cell gel electrophoresis (comet assay)
Single cell gel electrophoresis or comet assay is a simple,
sensitive and rapid method for the detection and quantifi-
cation of DNA damage [16]. Slides were prepared in du-
plicate per group and the test was performed for at least 3
different brain (cortex and medulla) samples from each
group. For the cell suspension, approximately 4 × 106 cells
were mixed with 80 μl of 0.7% low-melting agarose in
phosphate-buffered saline (PBS) at 37°C in a microtube,
and then spread over a window microscopic slide. The
slides were precoated with 150 μl of 0.5% normal-melting
agarose in PBS, and were specially designed for this assay.
The slides were immediately placed in cold lysis buffer
containing 2.5 M sodium chloride (NaCl), 100 mM EDTA
sodium salt Na2EDTA, 10 mM Tris (pH 10), and 1%
Triton X-100, at 4°C for a minimum of 1 hr. After lysis,
the slides were drained and placed in a horizontal gel
electrophoresis tank placed in ice, and filled with fresh
cold electrophoresis buffer (300 mM sodium hydroxide
(NaOH), 1 mM NaEDTA, pH 13). To allow uncoiling of
DNA, the slides were kept in the high pH buffer for 20 -
minutes. Subsequently, electrophoresis was carried out for
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drained and flooded slowly with 3 changes of neu-
tralization buffer (0.4 M Tris, pH 7.5) for 5 minutes each,
and then stained with 30 ml of ethidium bromide (20 mg/l)
and covered with cover slips. All those steps were per-
formed under dimmed light to prevent additional DNA
damage caused by visible light. A total of 50 randomly se-
lected cells per slide were analyzed. Imaging was performed
with a fluorescence microscope (Zeiss Axiovert L410
Inc., Jena Germany), attached to a digital camera (Olympus
Inc., Tokyo, Japan), and equipped with a 549 nm excitation
filter, 590 nm barrier filter, and a 100-W mercury lamp.
The percentage of DNA in the comet tail ("DNA damage")
was automatically calculated using a ‘Toolbox’ from the IN
Cell Investigator analysis package (GE Healthcare Life Sci-
ences). Tail moment was calculated as a product of tail
length multiplied by tail % damage.
Measurement of colon microbiota
Sample collection
Hamsters’ caecum samples were collected in sterile tubes
with clindamycin- induced ileocecitis and immediately
frozen at −70°C. The frozen tubes were sent to a micro-
biology laboratory for analysis. The process of bacterial
cultivation involved the use of optimal artificial media
and incubation conditions to isolate and identify the
colon microbiota of an animal as rapidly and as accur-
ately as possible.
Isolation procedures
Stools were usually watery, with a characteristic foul
odour, mucoid and soft. Gross blood in stool did occur in
some cases. Five different media were employed to isolate
colon microbiota. Stool samples were diluted in glycerol
transport broth [17] to yield a 1/10 dilution. Five percent
sheep blood agar (BAP), MacConkey agar (MAC), Muller
Hinton agar (MHA), Saboraud’s Dextrose agar (SDA) (as
selective medium for yeast) and modified cefoxitin cyclo-
serine fructose agar (CCFA) (as selective medium for C.
difficile) were used in the present study. For the quantifi-
cation of C. difficile, a sample of 0.1 ml of serial dilution
was plated on CCFA and incubated at 37°C for at least
72 h in the anaerobic jar [18]. For other aerobic microor-
ganisms, portions of 0.1 ml of 10-2, 10-3, and 10-4 dilutions
were plated with a glass spreader on to BAP, MAC, MHA,
and SDA. The inoculated plates were incubated at 37°C
for 2 days in aerobic conditions.
Identification criteria
Colonies of C. difficile growing on CCFA, and blood
agar were examined under long-wavelength ultraviolet
light (Mineralite UVSL-25; Ultraviolet Products, Inc.,
San Gabriel, Calif.) for fluorescence. Whenever fluores-
cence, colonial morphology, or Gram stain morphologywas characteristic of C. difficile, the isolate was identi-
fied by the criteria outlined in the Anaerobe Laboratory
Manual [19]. Yellow fluorescence of the colonies of C.
difficile on CCFA could be detected after 24 h of incuba-
tion and persisted for 5 to 6 days.
MAC or MHA and BAP media are recommended as pri-
mary plating media for most routine aerobic bacteriologic
cultures. On Muller-Hinton agar plates, several bacterial
species that were cultured under aerobic condition from
stool samples, before and after treatment of hamsters
with clindamycin, included Streptococcus, Staphylococcus
aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
There was an overgrowth of Candida albicans on SDA agar
plates.
Identification of microorganisms of clinically significant
streptococci (β hemolysis species), staphylococci, and a se-
lected group of Gram-positive bacilli could be detected on
blood agar plates after the treatment of hamsters with
clindamycin. Enterobacteriaceae (lactose fermenter micro-
organisms) were detected on MacConkey agar media after
administration of clindamycin to hamsters.
Quantitative study of bacterial flora
The quantification of culture-based methods was based
on a scale of ++++, defined as:
0 = no growth, < 103 colony forming units/gram of
feces
+ = Rare, less than 103 colony forming units/gram of
feces
++ = Few, 103 - 104 colony forming units/gram of feces
+++ = Moderate 105 - 106 colony forming units/gram
of feces
++++ = Heavy > 106 colony forming units/gram of
feces
(Colony-forming unit (CFU) is a measure of viable
bacterial or fungal numbers. Unlike direct microscopic
counts where all cells, dead and living, are counted, CFU
measures viable cells) For each dilution, the number of
colony forming units on the plates were counted. Typic-
ally, numbers between 30 and 300 were used to estimate
the culture count.
Statistical analysis
The data were analyzed using the statistical package for so-
cial sciences (IBM Corp., New York, NY, USA). The results
were expressed as mean ± S.D. All statistical comparisons
between the control and PA-treated hamster groups were
performed with the one-way ANOVA test complemented
with Dennett test for multiple comparisons. P < 0.05 was
statistically significant. ROC analysis was performed. Area
under the curve (AUC), cutoff values, and degree of speci-
ficity and sensitivity were calculated.
Table 1 Estimation of clindamycin-induced changes in
cecal flora of hamster






MHA/aerobic; 37°C/24 h ++ ++++
MAC/aerobic; 37°C/24 h 0 ++
BAP/aerobic; 37°C/24 h + ++
SDA/aerobic; 25°C/48 h + ++
CCFA/anaerobic; 37°C/72 h 0 ++
MHA: Muller Hinton Agar.
MAC: MacConkey Agar.
BAP: 5% Sheep Blood Agar.
SDA: Sabouroud Dextrose agar (yeast media).
CCFA: modified Cefoxitin Cycloserine Fructose Agar.
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The association between bacteria and inflammation is
complex as either can impact the other. Bacterial over-
growth could induce different levels of activation of the
various innate sensors, which can influence the gene
expression pathways, level of inflammation and the re-
sults of these changes on DNA damage and chromatin
alterations. Numerous studies [20-22] have verified the
association between an alteration of the dominant phyla
of bacteria in the gut and systemic effects in humans




Control Cortex 0.97 ±
Medulla 1.12 ±
Propionic acid Cortex 6.80 ±
Medulla 7.27 ±
Clindamycin Cortex 1.81 ±
Medulla 1.75 ±
Carnosine Cortex 1.10 ±
Medulla 1.15 ±
Carnitine Cortex 1.25 ±
Medulla 1.28 ±
PA +Carnosine Cortex 3.96 ±
Medulla 3.83 ±
PA +Carnitine Cortex 3.50 ±
Medulla 2.85 ±
clindamycin +Carnosine Cortex 1.58 ±
Medulla 1.68 ±
clindamycin+Carnitine Cortex 1.73 ±
Medulla 1.70 ±
Independent t-test between the control and PPA groups of Cortex and Medulla in T
* Significant at 0.05 level.
** Significant at 0.01 levelresistance, inflammation, and adiposity via interactions
with epithelial and endocrine cells [20]. The intestinal
epithelial cells (IECs) have a complex and mutually
beneficial relationship with the gut flora. The bacteria
metabolize some nutritional components in the gut, e.g.
carbohydrates; in turn, the IECs metabolize the short-
chain fatty acids (e.g. propionic and acetic acid) and use
them as a source of energy. The microflora in the gut is
essential for processing dietary polysaccharides. The data
in Table 1 indicate that clindamycin was effective in indu-
cing intestinal overgrowth of microbiota. The most striking
changes in feces of clindamycin-treated hamsters, as com-
pared with untreated controls, included, a marked increase
in total Clostridia species and Klebsiella pneumoniae, with
a smaller increase in Group A Streptococci. The low counts
of bacteria recovered from some of the specimens were
likely due to several factors including dilution effects of
diarrhea and the reduction in the number of viable bacteria
caused by freezing and/or prolonged storage at −70°C.
The induction of pathogenic bacteria in hamsters that
received clindamycin could be related to the etiology of
autistic biochemical characteristics previously induced in
rats that received oral propionic acid, a metabolite of
some pathogenic enteric bacteria [23]. It is well docu-
mented that autistic patients show bacterial overgrowth,eated, Clindamycin-treated, carnosine and carnitine
Parameters
gth (μm) Tail DNA % Tail moment
0.24 0.96 ± 0.33 0.98 ± 0.59
0.24 1.03 ± 0.32 1.21 ± 0.57
0.74** 6.10 ± 0.20** 41.51 ± 5.09**
1.33** 6.67 ± 0.99** 49.32 ±15.53**
0.32* 1.71 ± 0.36* 3.16 ± 1.26*
0.29* 1.64 ± 0.40 2.95 ± 1.25
0.14 1.05 ± 0.20 1.18 ± 0.36
0.15 1.00 ± 0.10 1.16 ± 0.27
0.07 1.13 ± 0.09 1.42 ± 0.19
0.03 1.07 ± 0.14 1.37 ± 0.17
0.09** 3.87 ± 0.45** 15.34 ± 2.11**
0.27** 3.69 ± 0.32** 14.19 ± 2.24**
0.60** 3.37 ± 0.47** 11.96 ± 3.80*
0.27** 2.63 ± 0.28** 7.56 ± 1.46**
0.10* 1.42 ± 0.09 2.25 ± 0.29*
0.07* 1.23 ± 0.12 2.07 ± 0.12
0.20* 1.54 ± 0.11* 2.67 ± 0.50*
0.21* 1.52 ± 0.06 2.60 ± 0.39*
ailed %, Untailed %, Tail length (μm), Tail DNA % and Tail moment.
Figure 1 DNA damage induced in hamster brains (cortex and medulla) by PA or clindamycin-induced bacterial overgrowth together
with the protective effects of carnosine and L-carnitine. Neurotoxic effects of PA, bacterial overgrowth and ameliorating effects of both the
supplements could be seen as significant changes in tail length (μm) and tail moments (Arbitrary units) (A & B respectively) and percentage
changes in both (C & D). All figures are presented as mean±SE bars in the 8 studied groups compared to a control group. It is clear that orally
administered PA was more neurotoxic than induced bacterial overgrowth. Carnosine was more protective than carnitine.
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clindamycin), which can alter gut flora [24-27]. Oral
antibiotics are commonly used by autistics for treating
otitis media (ear infections), which occurs frequently in
these patients. This observation may suggest an impaired
immune system, a biochemical feature related to PA
induced brain toxicity in rats [23]. Commonly used oral
antibiotics eliminate almost all of the normal gut micro-
biota, which play an important role in the breakdown of
plant polysaccharides, promoting gastrointestinal motil-
ity, maintaining water balance, producing some vitamins,
and competing against pathogenic bacteria. Thus loss of
normal gut flora with clindamycin could result in the
overgrowth of pathogenic flora identified in Table 1.
This observation is supported by Buffie et al’s [28] study
that found a single dose of clindamycin results in the
reduction of the normal diversity of the intestinal micro-
biota for at least 28 days and induces sustained suscepti-
bility to C. difficile toxins such as propionic acid.
Table 2, Figure 1A-D and Figure 2A & B demonstrate
PA and clindamycin induced DNA damage in the cortex
and medulla of treated hamsters. The evidence for DNA
damage is the significant increase in the comet parame-
ters, presented as tail length (μm) in figures A and B, tail
DNA(%) and tail moment (arbitrary units). It is clear that
DNA damage produced by bacterial overgrowth induced
by clindamycin-treatment was not comparable to that
produced by orally administered PA in the hamsters. For
example, PA induced approximately a 700% increase in
tail length and tail moment, whereas, bacterial overgrowthinduced a 180% increase in both the parameters. Our re-
sults indicate that the measurement of the percentages of
tail DNA gives additional information on the extent of
DNA damage in the cortex and medulla of PA-treated
hamsters. Thus, high levels of DNA double strand breaks
showed increased comet tail fluorescent intensity with
ethidium bromide staining. This could prove that PA not
only penetrates the blood–brain barrier, but it can also
induce DNA damage in brain cells. The primary mecha-
nism of PA-induced DNA damage is not fully understood.
We postulate that PA, similar to its derivative 3-
nitropropionic acid (3 N-PA), could inhibit complex II of
the respiratory chain leading to a rapid decline in ATP
levels followed by mitochondrial DNA damage and dys-
function. ATP depletion, and mitochondrial dysfunctions
are two mechanisms involved in the pathophysiology of
autism [29], the postulated mechanism of PA toxicity,
could confirm the role of the persisting effect of PA in the
aetiology of biochemical features associated to autism as
reported by El-Ansary et al. [23] in PA-treated rat pups.
DNA strand breaks in the cortex and medulla of
clindamycin-treated hamsters could be indirectly caused
by PA as a metabolite of the induced pathogenic bacteria
and due to the increased susceptibility of treated hamsters
to C. difficile [28]. The remarkably higher effect of orally
administered PA is likely related to the significant differ-
ence in the toxic dose administered.
Thus, clindamycin induced DNA damage could be
attributed to the overgrowth of anaerobic bacteria, e.g.
Clostridium that has recently been implicated as a
Figure 2 Measure of PA or clindamycin-induced DNA damage by comet assay. (A) Photograph showing comet tailing in PA and clindamycine
treated hamsters together with the protective effects of carnosine and carnitine in cortex; (B) Photograph showing comet tailing in PA and clindamycine
treated hamsters together with the protective effects of carnosine and carnitine in medulla.
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observation is supported by stool studies, which proved
that certain Clostridia were important and that siblings of
autistic children show intermediate Clostridia growth be-
tween healthy controls and their affected siblings [8,30].
It has been proposed that oxidative stress is related to
a time-dependent shift in the antioxidant/prooxidant
balance towards oxidative damage. Increased production
of oxidants in vivo can cause damage to intracellular
macromolecules such as DNA, proteins and lipids,
which can in turn lead to oxidative injury. Additionally,the increased nuclear DNA damage in PA and clin-
damycin treated animals could be related to oxidative
stress status in both groups of hamsters compared to the
healthy control group. Oxidative damage by a reactive
oxygen species (ROS) producing toxicity can affect DNA
integrity to a different extent [31,32]. This is consistent
with a recent study by El-Ansary et al. [23], which
reported increased lipid peroxides as an index of oxida-
tive stress, coupled with depletion of reduced gluta-
thione and lower catalase and glutathione peroxidase
activities in PA-treated rat pups.
Table 3 ROC-curve results for tail moment of brain cortex and medulla of the different studied groups showing AUC,
best cut-off values, specificity and sensitivity
Parameter Group Area under the curve Best cutoff value Sensitivity % Specificity %
Cortex Propionic acid 1.000 19.465 100.0% 100.0%
Clindamycin 1.000 1.968 100.0% 100.0%
Carnosine 0.667 0.720 100.0% 66.7%
Carnitine 0.667 0.950 100.0% 66.7%
Propionic acid+Carnosine 1.000 7.640 100.0% 100.0%
Propionic acid+Carnitine 1.000 5.642 100.0% 100.0%
Clindamycin +Carnosine 1.000 1.822 100.0% 100.0%
Clindamycin +Carnitine 1.000 1.931 100.0% 100.0%
Medulla Propionic acid 1.000 17.147 100.0% 100.0%
Clindamycin 1.000 1.910 100.0% 100.0%
Carnosine 0.556 1.209 66.7% 66.7%
Carnitine 0.444 0.882 100.0% 33.3%
Propionic acid+Carnosine 1.000 6.954 100.0% 100.0%
Propionic acid+Carnitine 1.000 3.905 100.0% 100.0%
Clindamycin +Carnosine 1.000 1.794 100.0% 100.0%
Clindamycin +Carnitine 1.000 1.963 100.0% 100.0%
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carrier to transport long-chain fatty acids (e.g. propionic
acid) into the mitochondria for beta-oxidation. In the
present study, the effect of L-carnitine, a widely recog-
nized essential nutrient, was evaluated on the status of
DNA damage induced in hamsters. Table 2 also demon-
strates the potency of L-carnitine in protecting against
PA neurotoxicity. It ameliorates the DNA damaging
effects of both treatments especially in PA-treated ham-
sters which had a 400% recovery for the cortex and
280% recovery for the medulla. This finding supports a
recent study by Ribas et al. [33] who reported that
propionic acidemia leads to severe metabolic compli-
cations in the neonatal period and to long-term neuro-
logical manifestations. They [33] evaluated the in vitro
effects of PA with or without L-carnitine, on DNA damage
in peripheral leukocytes, as determined by alkaline comet
assay. PA induced DNA damage index (DI) was signifi-
cantly higher than the control group [33]. L-carnitineTable 4 Pearson correlations coefficients and significance lev
and medulla
Parameters
Cortex Tail length ~ Tail DNA %
Tail length ~ Tail moment
Tail moment ~ Tail DNA %
Medulla Tail length ~ Tail DNA %
Tail length ~ Tail moment
Tail moment ~Tail DNA %
a
. Positive Correlation.significantly reduced the PA induced DNA damage, in a
concentration-dependent manner [33]. Administration of
L-carnitine significantly decreased the levels of lipid per-
oxides and improved the activities of antioxidant enzymes
such as superoxide dismutase, catalase, glutathione pero-
xidase and glutathione reductase [34]. This group of anti-
oxidant enzymes are affected by PA neurotoxicity and
are clinically impaired in autistic patients compared to
controls [23]. Additionally, a protective effect of carnitine
reported in the present study is likely due to L-carnitine
enhanced T-cell proliferative response and significantly re-
duced DNA damage, apoptosis and TNF-alpha levels in
the lymphocytes of aged animals [34] and in the brain of
PA-intoxicated rat pups (unpublished work).
Table 2 demonstrates the effect of carnosine in inducing
300% and 350% recovery for PA-intoxicated cortex and
medulla respectively. The remarkable protective effect of
carnosine reported in the present study concurs with
reports. Carnosine performs critical biological functions,els between DNA %, tail length and tail moment in cortex








Figure 3 Pearson`s positive correlations with the best fit line of the three Comet assay parameters.
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pression of free radical reactions [35,36]. It is well known
that the imidazolium group of histidine or carnosine stabi-
lizes adducts formed at the primary amino group and may
perform a crucial function as an anti-crosslinking agent
[37]. The results of many biochemical studies have sug-
gested that carnosine harbours free radical-scavenging ac-
tivity, which may partly explain its apparent homeostatic
functions [38,39]. Recently, in vitro and in vivo studies
have shown that carnosine can exert neuroprotective
effects via a variety of mechanisms [40]. It has been
reported that carnosine quenches 50–95% of the hydroxyl
radicals generated in the Fenton reaction [41]. Therefore,
it was suggested that the ability of carnosine to inhibitferritin-mediated DNA damage was likely attributable to
free radical-scavenging activity. In a more recent study,
carnosine was reported to protect neurons from lipid
peroxide-induced cell injury [42].
The low or non-significant effects of both carnitine and
carnosine in case of clindamycin-treated samples could be
attributed to the metabolic activity of the induced growth
of bacteria. Bacterial metabolic activity expressed as the
fermentation profile, or short-chain fatty acid profiles, may
reduce the sensitivity of colonocytes to both agents [43,44].
Table 3 shows the specificity, sensitivity of tail length
and tail moment in the 8 groups studied. It is clear that
the specificity and sensitivity for the parameters studied
were almost 100% in PA or clindamycin-treated groups
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the tail length and tail moment can be used as biomarkers
for PA-related neurotoxicity and for the carnosine and/or
carnitine neuroprotective effects. The three measured pa-
rameters positively correlated with statistically significant
P values (P<0.001, all parameters) (Table 4 & Figure 3).
Based on this study, we can suggest that the general
abuse of antibiotics leads to overgrowth of Clostridia
species as PA producers. The more pronounced effects of
orally administered PA compared to clindamycin-treated
hamsters observed in the present study could be attri-
buted to the effect of diet which undoubtedly plays a
major role in PA production as a bacterial metabolite [45].
Stated differently, key factors in the virulence of bac-
terial overgrowth and its mechanism leading to autism
are the production of PA as an enteric bacterial fermen-
tation product that is usually increased in the presence
of a high carbohydrate diet [46]. Based on this study, a
diet excluding complex carbohydrates or diets high in
anti-oxidants (e.g. carnitine and/or carnosine) may sub-
jectively give positive results in controlling the increa-
sing prevalence of autism. This conclusion is admittedly
tough to prove mechanistically and requires further
study emphasizing the role of the gut-brain axis in the
pathoetiology of autism [47].
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